DK0774963T3 - Farmaceutisk stabilt oxaliplatin-præparat - Google Patents

Farmaceutisk stabilt oxaliplatin-præparat

Info

Publication number
DK0774963T3
DK0774963T3 DK95925976T DK95925976T DK0774963T3 DK 0774963 T3 DK0774963 T3 DK 0774963T3 DK 95925976 T DK95925976 T DK 95925976T DK 95925976 T DK95925976 T DK 95925976T DK 0774963 T3 DK0774963 T3 DK 0774963T3
Authority
DK
Denmark
Prior art keywords
pct
oxaliplatinum
pharmaceutically stable
preparation
sec
Prior art date
Application number
DK95925976T
Other languages
Danish (da)
English (en)
Inventor
Houssam Ibrahim
Rolland-Yves Mauvernay
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50845249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0774963(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Application granted granted Critical
Publication of DK0774963T3 publication Critical patent/DK0774963T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK95925976T 1994-08-08 1995-08-07 Farmaceutisk stabilt oxaliplatin-præparat DK0774963T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH246294 1994-08-08
PCT/IB1995/000614 WO1996004904A1 (fr) 1994-08-08 1995-08-07 Preparation pharmaceutiquement stable d'oxaliplatine

Publications (1)

Publication Number Publication Date
DK0774963T3 true DK0774963T3 (da) 2001-01-29

Family

ID=50845249

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95925976T DK0774963T3 (da) 1994-08-08 1995-08-07 Farmaceutisk stabilt oxaliplatin-præparat

Country Status (17)

Country Link
US (1) US5716988A (cs)
EP (1) EP0774963B1 (cs)
JP (1) JP3547755B2 (cs)
KR (1) KR100365171B1 (cs)
CN (1) CN1138541C (cs)
AT (1) ATE197249T1 (cs)
AU (2) AU2989695A (cs)
BR (1) BR9508554A (cs)
CA (1) CA2196922C (cs)
CZ (1) CZ286714B6 (cs)
DE (1) DE69519300T2 (cs)
DK (1) DK0774963T3 (cs)
ES (1) ES2152412T3 (cs)
IL (1) IL114852A (cs)
RU (1) RU2148400C1 (cs)
UA (1) UA42779C2 (cs)
WO (1) WO1996004904A1 (cs)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0774963T3 (da) 1994-08-08 2001-01-29 Debiopharm Sa Farmaceutisk stabilt oxaliplatin-præparat
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
DK1121117T3 (da) * 1998-10-14 2002-09-16 Debiopharm Sa Indpakning af et oxaliplatinholdigt præparat
GB9904386D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
PT1207875E (pt) * 1999-08-30 2004-02-27 Debiopharm Sa Preparacao farmaceutica estavel de oxaliplatina para administracao via parenteral
US7070796B1 (en) * 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
WO2002047725A2 (fr) * 2000-12-12 2002-06-20 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
DE20221679U1 (de) * 2001-03-02 2006-11-23 Debiopharm S.A. Vorrichtung zur Konditionierung einer Oxaliplatinlösung
WO2003004505A1 (en) * 2001-07-02 2003-01-16 Debiopharm S.A. Oxaliplatin active substance with a very low content of oxalic acid
TWI315982B (en) 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
CA2537170A1 (en) * 2003-08-28 2005-03-10 Mayne Pharma Pty Ltd Acid containing oxaliplatin formulations
CA2547275A1 (en) 2003-11-25 2005-06-09 Platco Technologies (Proprietary) Limited Platinum(ii) complexes, preparation and use
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
JP5578753B2 (ja) * 2004-06-09 2014-08-27 大鵬薬品工業株式会社 抗腫瘍効果増強剤、抗腫瘍剤及び癌治療方法
ES2327346T3 (es) * 2004-09-01 2009-10-28 Platco Technologies (Proprietary) Limited Preparacion de complejos de platino (ii).
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2007029268A2 (en) 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
ZA200806748B (en) * 2006-01-30 2010-01-27 Platco Technologies Proprietar Preparation of platinum (II) complexes
AU2007227466B2 (en) * 2006-03-16 2011-11-17 Bionumerik Pharmaceuticals, Inc. Anti-cancer activity augmentation compounds and formulations and methods of use thereof
BRPI0711385A2 (pt) 2006-05-09 2011-11-08 Novartis Ag combinação compreendendo um quelante de ferro e um agente anti-neoplástico e seu uso
DK2101805T3 (da) * 2007-01-18 2013-01-21 Merck Patent Gmbh Integrinligander til anvendelse i behandling af cancer
US20090076139A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched oxalplatin
EP2152239A1 (en) * 2007-11-12 2010-02-17 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
WO2009113989A1 (en) 2008-03-14 2009-09-17 Bionumerik Pharmaceuticals, Inc. Compositions and methods of use of compounds to increase cancer patient survival time
JP5694782B2 (ja) 2008-03-14 2015-04-01 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 肺癌、腺癌及び他の病状のための治療方法及び組成物
US9393201B2 (en) 2009-09-21 2016-07-19 Jw Pharmaceutical Corporation Oxaliplatin nanoparticles and method for preparing same
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
AU2013202575B1 (en) * 2012-01-04 2013-05-16 Hospira, Inc. Dexmedetomidine premix formulation
JP5314790B1 (ja) * 2012-07-09 2013-10-16 東和薬品株式会社 オキサリプラチン含有医薬組成物
ES2733061T3 (es) 2012-08-10 2019-11-27 Taiho Pharmaceutical Co Ltd Dispersión acuosa de liposomas encapsulantes de oxaliplatino estable y método para estabilización de la misma
TWI698253B (zh) 2012-09-07 2020-07-11 美商柯赫勒斯生物科學有限公司 阿達木單抗（ａｄａｌｉｍｕｍａｂ）之穩定水性調配物
CN103690494B (zh) * 2013-11-29 2015-04-15 杭州华东医药集团新药研究院有限公司 一种低杂质含有奥沙利铂的组合物及其制备方法
CA2953350C (en) 2014-06-23 2019-11-26 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
MX2018000283A (es) 2015-07-07 2018-11-22 H Lundbeck As Inhibidores de fde9 con estructura basica de imidazotriazinona y estructura basica de imidazopirazinona en el tratamiento de enfermedades perifericas.
CN104940151A (zh) * 2015-07-23 2015-09-30 青岛蓝盛洋医药生物科技有限责任公司 一种抗癌药物奥沙利铂冻干粉针剂组合物
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
US11071782B2 (en) 2016-04-20 2021-07-27 Coherus Biosciences, Inc. Method of filling a container with no headspace
US10987353B2 (en) 2016-05-04 2021-04-27 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
MX2018016127A (es) 2016-07-06 2019-05-30 Imara Inc Inhibidores de pde9 para el tratamiento de enfermedades perifericas.
TWI791021B (zh) 2017-05-26 2023-02-01 美商伊馬拉公司 製備和使用ｐｄｅ９抑制劑之方法
EP3801526B1 (en) 2018-05-25 2023-12-27 Imara Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
IL83380A (en) * 1987-07-30 1991-04-15 Teva Pharma Stable aqueous cisplatin solutions
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.
JPH04185601A (ja) * 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
JP2673331B2 (ja) * 1993-01-12 1997-11-05 田中貴金属工業 株式会社 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
WO1994012193A1 (fr) * 1992-11-24 1994-06-09 Debiopharm S.A. Combinaison de cisplatine avec l'oxaliplatine
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
DK0774963T3 (da) 1994-08-08 2001-01-29 Debiopharm Sa Farmaceutisk stabilt oxaliplatin-præparat

Also Published As

Publication number Publication date
KR100365171B1 (ko) 2003-02-19
UA42779C2 (uk) 2001-11-15
EP0774963A1 (fr) 1997-05-28
JPH10508289A (ja) 1998-08-18
ES2152412T3 (es) 2001-02-01
US5716988A (en) 1998-02-10
DE69519300T2 (de) 2001-05-31
IL114852A (en) 2000-02-29
AU2252499A (en) 2000-03-23
WO1996004904A1 (fr) 1996-02-22
CA2196922A1 (fr) 1996-02-22
DE69519300D1 (de) 2000-12-07
CN1154654A (zh) 1997-07-16
CA2196922C (fr) 2004-06-01
ATE197249T1 (de) 2000-11-15
AU731981B2 (en) 2001-04-12
KR970704434A (ko) 1997-09-06
RU2148400C1 (ru) 2000-05-10
JP3547755B2 (ja) 2004-07-28
CN1138541C (zh) 2004-02-18
AU2989695A (en) 2000-03-07
EP0774963B1 (fr) 2000-11-02
BR9508554A (pt) 1997-11-25
IL114852A0 (en) 1995-12-08
CZ37997A3 (en) 1997-06-11
CZ286714B6 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
DK0774963T3 (da) Farmaceutisk stabilt oxaliplatin-præparat
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
PT1251750E (pt) Formula pediatrica melhorada e metodos para proporcionar nutricao e melhorar a tolerancia
NO20054324L (no) Anvendelse av ranolazin og minst ett pH-avhengig bindemiddel for fremstilling av ranolazinpreparater med depotvirkning
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
AU2001288460A1 (en) Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
MXPA02008654A (es) Formulaciones de ranolazina de liberacion prolongada.
KR920007629A (ko) SALMe염, 5-MTHF 및 5-FTHF 중에서 선택된 화합물 적어도 1개를 유효성분으로서 함유하여 AIDS환자의 신경학적 질환치료시 활성을 나타내는 약제학적 조성물
HK1046090A1 (en) Use of l-carnitine and its alkanoyl derivatives asosmotic agents in solutions for medical use
HUP0202749A2 (hu) Levoszimendánt tartalmazó oldat formájú gyógyszerkészítmény
ATE350024T1 (de) Flüssige zubereitung enthaltend tobramycin
EE04264B1 (et) Naatriumkloriidi kasutamine aine valmistamiseks kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsete kõrvaltoimete vähendamiseks
ES404959A1 (es) Un procedimiento para preparar una composicion acuosa es- table de dexiciclina.
NZ507407A (en) Stable mitoxantrone solutions
CA2015632A1 (en) Stable solutions of rebeccamycin analog and preparations thereof
AU2001289762A1 (en) Pharmaceutical extemporary compositions
DK1019037T3 (da) Lægemiddel indeholdende delta-aminolevulinsyre
HK1036413A1 (en) Solution comprising prostaglandins and benzyl alcohol.
GB1246315A (en) Pharmaceutical compositions
Lin et al. Toxicity of a single oral dose of N-ethylphenylacetamide in rats
ES2125800A1 (es) Conjunto de infusion final.
MY104837A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
RU94036715A (ru) Лекарственное средство для лечения железодефицитных анемий у детей